Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades UserTesting to Neutral, Announces $7.5 Price Target

JP Morgan Downgrades UserTesting to Neutral, Announces $7.5 Price Target

JP Morgan analyst Pinjalim Bora downgrades UserTesting (NYSE:USER) from Overweight to Neutral and announces $7.5 price target.

byBenzinga Newsdesk

October 27, 2022

1 minute read

JP Morgan analyst Pinjalim Bora downgrades UserTesting (NYSE:USER) from Overweight to Neutral and announces $7.5 price target.

Analyst Ratings

Argus Research Maintains Buy Rating for Silk Road Medical: Here’s What You Need To Know

By Benzinga Insights

May 22, 1:00 PM

Argus Research has decided to maintain its Buy rating of Silk Road Medical (NASDAQ:SILK) and lower its price…

SILK

Stifel Maintains Hold on Donaldson, Lowers Price Target to $51

By Benzinga Newsdesk

July 18, 7:25 AM

Stifel analyst Nathan Jones maintains Donaldson (NYSE:DCI) with a Hold and lowers the price target from $53 to $51.

DCI

Wendy’s Q3 EPS $0.24 Beats $0.23 Estimate, Sales $532.57M Miss $539.41M Estimate

By Bill Haddad

November 9, 8:00 AM

Wendy's (NASDAQ:WEN) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.23 by 4.35 percent. This is a 26.32 percent increase over earnings of $0.19 per share from the same

WEN

What’s Going On With Stryker Stock Today

By Vandana Singh

May 2, 9:49 AM

The orthopedic and surgical device giant Stryker Corporation (NYSE: SYK) stock is trading lower despite reporting Q1 earnings beat and an upbeat outlook.

SYK

JP Morgan Downgrades UserTesting to Neutral, Announces $7.5 Price Target

Related Posts

Argus Research Maintains Buy Rating for Silk Road Medical: Here’s What You Need To Know

Stifel Maintains Hold on Donaldson, Lowers Price Target to $51

Wendy’s Q3 EPS $0.24 Beats $0.23 Estimate, Sales $532.57M Miss $539.41M Estimate

What’s Going On With Stryker Stock Today